Divya Shah

SARS-CoV-2 evolution during treatment of chronic infection

Steven A. Kemp, Dami A. Collier, Rawlings Datir et al. · Nature · 2021 · 1.1K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Erik Volz, Verity Hill, John T. McCrone et al. · Cell · 2020 · 1.1K citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Brian J. Willett, Joe Grove, Oscar A. MacLean et al. · Nature Microbiology · 2022 · 724 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira et al. · Nature · 2021 · 716 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial

Cornelia L. Trimble, Matthew P. Morrow, Kimberly A. Kraynyak et al. · The Lancet · 2015 · 714 citations

Medicine, Immunology, Oncology +17